- Home
- PENG vs NVAX Comparison
PENG vs NVAX Comparison
Compare PENG & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENG
- NVAX
- Stock Information
- Founded
- PENG 1988
- NVAX 1987
- Country
- PENG Cayman Islands
- NVAX United States
- Employees
- PENG N/A
- NVAX N/A
- Industry
- PENG Semiconductors
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PENG Technology
- NVAX Health Care
- Exchange
- PENG Nasdaq
- NVAX Nasdaq
- Market Cap
- PENG 1.2B
- NVAX 1.3B
- IPO Year
- PENG 2017
- NVAX 1995
- Fundamental
- Price
- PENG $24.35
- NVAX $7.84
- Analyst Decision
- PENG Strong Buy
- NVAX Hold
- Analyst Count
- PENG 8
- NVAX 6
- Target Price
- PENG $27.13
- NVAX $15.00
- AVG Volume (30 Days)
- PENG 862.7K
- NVAX 8.6M
- Earning Date
- PENG 10-14-2025
- NVAX 08-06-2025
- Dividend Yield
- PENG N/A
- NVAX N/A
- EPS Growth
- PENG N/A
- NVAX N/A
- EPS
- PENG N/A
- NVAX 2.54
- Revenue
- PENG $1,342,020,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- PENG $19.58
- NVAX $52.02
- Revenue Next Year
- PENG $8.64
- NVAX N/A
- P/E Ratio
- PENG N/A
- NVAX $3.08
- Revenue Growth
- PENG 14.09
- NVAX 9.22
- 52 Week Low
- PENG $14.20
- NVAX $5.01
- 52 Week High
- PENG $25.94
- NVAX $15.22
- Technical
- Relative Strength Index (RSI)
- PENG 56.36
- NVAX 48.26
- Support Level
- PENG $22.90
- NVAX $7.57
- Resistance Level
- PENG $25.14
- NVAX $10.64
- Average True Range (ATR)
- PENG 0.85
- NVAX 0.72
- MACD
- PENG -0.07
- NVAX -0.07
- Stochastic Oscillator
- PENG 70.85
- NVAX 29.47
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.